Mark-David Levin
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Fürstenau M, Thus Y, Robrecht S, Mellink C, van der Kevie-Kersemaekers A, Dubois J, von Tresckow J, Patz M, Gregor M, Thornton P, Staber P, Tadmor T, Levin M, da Cunha-Bang C, Schneider C, Poulsen C, Illmer T, Schöttker B, Janssens A, Christiansen I, Noesslinger T, Baumann M, Hebart H, Gaska T, Regelink J, Dompeling E, Lindstrom V, Juliusson G, Widmer A, Goede J, Goldschmidt N, Simon F, De Silva N, Fink A, Fischer K, Wendtner C, Ritgen M, Brüggemann M, Tausch E, Spaargaren M, Eldering E, Stilgenbauer S, Niemann C, Hallek M, Eichhorst B, Kreuzer K, Kater A. High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood 2023
May 12, 2023High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
May 12, 2023Blood 2023
Fürstenau Moritz, Thus Yvonne J, Robrecht Sandra, Mellink Clemens H M, van der Kevie-Kersemaekers Anne-Marie F, Dubois Julie, von Tresckow Julia, Patz Michaela, Gregor Michael, Thornton Patrick, Staber Philipp B, Tadmor Tamar, Levin Mark-David, da Cunha-Bang Caspar, Schneider Christof, Poulsen Christian Bjørn, Illmer Thomas, Schöttker Björn, Janssens Ann, Christiansen Ilse, Noesslinger Thomas, Baumann Michael, Hebart Holger, Gaska Tobias, Regelink Josien, Dompeling Ellen C, Lindstrom Vesa, Juliusson Gunnar, Widmer Anouk Andrea, Goede Jeroen, Goldschmidt Neta, Simon Florian, De Silva Nisha, Fink Anna Maria, Fischer Kirsten, Wendtner Clemens-Martin, Ritgen Matthias, Brüggemann Monika, Tausch Eugen, Spaargaren Marcel, Eldering Eric, Stilgenbauer Stephan, Niemann Carsten Utoft, Hallek Michael, Eichhorst Barbara, Kreuzer Karl-Anton, Kater Arnon P
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann C, Kater A, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber P, Tadmor T, Lindstrom V, da Cunha-Bang C, Schneider C, Poulsen C, Illmer T, Schöttker B, Noesslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, Klift M, Jäger U, Leys M, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink J, Widmer A, Simon F, De Silva N, Fink A, Bahlo J, Fischer K, Wendtner C, Kreuzer K, Ritgen M, Brüggemann M, Tausch E, Levin M, van Oers M, Geisler C, Stilgenbauer S, Hallek M, GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia. N Engl J Med 2023; 388:1739-1754.
May 11, 2023First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
May 11, 2023N Engl J Med 2023; 388:1739-1754
Eichhorst Barbara, Niemann Carsten Utoft, Kater Arnon P, Fürstenau Moritz, von Tresckow Julia, Zhang Can, Robrecht Sandra, Gregor Michael, Juliusson Gunnar, Thornton Patrick, Staber Philipp B, Tadmor Tamar, Lindstrom Vesa, da Cunha-Bang Caspar, Schneider Christof, Poulsen Christian Bjørn, Illmer Thomas, Schöttker Björn, Noesslinger Thomas, Janssens Ann, Christiansen Ilse, Baumann Michael, Frederiksen Henrik, Klift Marjolein van der, Jäger Ulrich, Leys Maria B L, Hoogendoorn Mels, Lotfi Kourosh, Hebart Holger, Gaska Tobias, Koene Harry, Enggaard Lisbeth, Goede Jereon, Regelink Josien, Widmer Anouk Andrea, Simon Florian, De Silva Nisha, Fink Anna Maria, Bahlo Jasmin, Fischer Kirsten, Wendtner Clemens-Martin, Kreuzer Karl A, Ritgen Matthias, Brüggemann Monika, Tausch Eugen, Levin Mark-David, van Oers Marinus, Geisler Christian, Stilgenbauer Stephan, Hallek Michael, GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
Sonneveld P, Driessen C, Pour L, Levin M, Bos G, Ypma P, Wu K, van de Velden V, Oliva S, Broijl A, Croockewit A, Boccadoro M, Spencer A, Palumbo G, Offidani M, van de Donk N, Hveding C, Waage A, Minnema M, Troia R, Cornelisse P, Zamagni E, Zander T, Zweegman S, Ludwig H, Aquino S, van der Holt B, Beksac M, Dimopoulos M, Wester R, Hájek R, Gulbrandsen N, Gregersen H, Morelli A, De Rosa L, Cafro A, Gay F, Dozza L, Pantani L, Cavo M. Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. J Clin Oncol 2021; 39:3613-3622.
Sep 14, 2021Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
Sep 14, 2021J Clin Oncol 2021; 39:3613-3622
Sonneveld Pieter, Driessen Christoph, Pour Luca, Levin Mark-David, Bos Gerard, Ypma Paula F, Wu KaLung, van de Velden Vincent, Oliva Stefania, Broijl Annemiek, Croockewit Alexandra, Boccadoro Mario, Spencer Andrew, Palumbo Giuseppe A, Offidani Massimo, van de Donk Niels W C J, Hveding Cecilie, Waage Anders, Minnema Monique C, Troia Rosella, Cornelisse Petra, Zamagni Elena, Zander Thilo, Zweegman Sonja, Ludwig Heinz, Aquino Sara, van der Holt Bronno, Beksac Meral, Dimopoulos Meletios A, Wester Ruth, Hájek Roman, Gulbrandsen Nina, Gregersen Henrik, Morelli Annamaria, De Rosa Luca, Cafro AnneMaria, Gay Francesca, Dozza Luca, Pantani Lucia, Cavo Michele
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Sonneveld P, von dem Borne P, Durian M, Hájek R, Boersma R, Wu K, Morelli A, Aquino S, Ludwig H, Bos G, Levin M, Benevolo G, Pascarella A, Troia R, Caravita di Toritto T, Zander T, Boccadoro M, Spencer A, Carvalho S, Palmas A, Cafro A, Mandigers C, Minnema M, van Marwijk Kooy M, Mellqvist U, Gimsing P, Waage A, Specchia G, Driessen C, Broijl A, Andersen N, Patriarca F, Palumbo G, Zamagni E, van der Velden V, Oliva S, Zweegman S, van der Holt B, Dozza L, Dimopoulos M, Petrucci M, Pantani L, Beksac M, Gay F, Montefusco V, Galli M, Liberati A, Zambello R, Vincelli I, Offidani M, Ballanti S, Croockewit A, Grasso M, Ypma P, Pour L, Belotti A, Hansson M, Gamberi B, Maisnar V, Cavo M. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Lancet Haematol 2020; 7:e456-e468.
Apr 30, 2020Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Apr 30, 2020Lancet Haematol 2020; 7:e456-e468
Sonneveld Pieter, von dem Borne Peter A, Durian Marc, Hájek Roman, Boersma Rinske, Wu Ka Lung, Morelli Anna Maria, Aquino Sara, Ludwig Heinz, Bos Gerard, Levin Mark-David, Benevolo Giulia, Pascarella Anna, Troia Rossella, Caravita di Toritto Tommaso, Zander Thilo, Boccadoro Mario, Spencer Andrew, Carvalho Susanna, Palmas Angelo, Cafro Anna Maria, Mandigers Caroline, Minnema Monique, van Marwijk Kooy Marinus, Mellqvist Ulf-Henrik, Gimsing Peter, Waage Anders, Specchia Giorgina, Driessen Christoph, Broijl Annemiek, Andersen Niels Frost, Patriarca Francesca, Palumbo Giuseppe A, Zamagni Elena, van der Velden Vincent H J, Oliva Stefania, Zweegman Sonja, van der Holt Bronno, Dozza Luca, Dimopoulos Meletios A, Petrucci Maria Teresa, Pantani Lucia, Beksac Meral, Gay Francesca, Montefusco Vittorio, Galli Monica, Liberati Anna Marina, Zambello Renato, Vincelli Iolanda D, Offidani Massimo, Ballanti Stelvio, Croockewit Alexsandra, Grasso Mariella, Ypma Paula, Pour Ludek, Belotti Angelo, Hansson Markus, Gamberi Barbara, Maisnar Vladimir, Cavo Michele